A detailed history of Sandhill Capital Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sandhill Capital Partners LLC holds 2,582 shares of NVO stock, worth $289,029. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,582
Previous 2,582 -0.0%
Holding current value
$289,029
Previous $331,000 11.18%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $51,055 - $67,960
-500 Reduced 16.22%
2,582 $331,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $140,138 - $307,491
1,541 Added 100.0%
3,082 $280,000
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $39,702 - $47,741
-300 Reduced 16.3%
1,541 $245,000
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $188,794 - $249,142
1,841 New
1,841 $249,000
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $171,397 - $207,186
1,841 New
1,841 $204,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sandhill Capital Partners LLC Portfolio

Follow Sandhill Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandhill Capital Partners LLC with notifications on news.